Cargando…
Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation)
Glioblastoma (GB), a grade IV glioma, with high heterogeneity and chemoresistance, obligates a multidimensional antagonist to debilitate its competence. Considering the previous reports on thioesters as antitumor compounds, this paper investigates on use of this densely functionalized sulphur rich m...
Autores principales: | Viswanathan, Anisha, Musa, Aliyu, Murugesan, Akshaya, Vale, João R., Afonso, Carlos A. M., Konda Mani, Saravanan, Yli-Harja, Olli, Candeias, Nuno R., Kandhavelu, Meenakshisundaram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953096/ https://www.ncbi.nlm.nih.gov/pubmed/31842391 http://dx.doi.org/10.3390/cells8121624 |
Ejemplares similares
-
Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624
por: Viswanathan, Anisha, et al.
Publicado: (2020) -
Identifying the miRNA Signature Association with Aging-Related Senescence in Glioblastoma
por: Gnanavel, Mutharasu, et al.
Publicado: (2021) -
Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent
por: Le, Hien Thi Thu, et al.
Publicado: (2019) -
Synthesis and Preclinical
Validation of Novel Indole
Derivatives as a GPR17 Agonist for Glioblastoma Treatment
por: Nguyen, Phung, et al.
Publicado: (2021) -
Alkylaminophenol and GPR17 Agonist for Glioblastoma Therapy: A Combinational Approach for Enhanced Cell Death Activity
por: Doan, Phuong, et al.
Publicado: (2021)